Treatment of Chronic Portal Vein Thrombosis in Cirrhosis with Portal Hypertension Complications
Clinical Scenario
Liver Cirrhosis
This protocol addresses patients with liver cirrhosis and chronic portal vein thrombosis — defined as portal vein occlusion present or persistent for more than 6 months — who have developed complications of portal hypertension, including variceal bleeding, refractory ascites, or hepatic hydrothorax.
Why This Presentation Matters
When chronic PVT occurs in the context of cirrhosis, portal hypertension and its sequelae — variceal hemorrhage, ascites that no longer responds to standard management, and hepatic hydrothorax — define the severity of the clinical picture and directly shape the approach to management.
Approach
Management in this scenario involves endoscopic intervention targeting the complications of portal hypertension. The structured protocol specifies the sequence, selection criteria, and supporting measures — details that go beyond this summary.
Full regimen, selection criteria, and clinical decision points are available via the link below.
References
DOI: 10.1016/j.tvir.2025.101084
- Chronic PVT present or persistent for >6 months.
- The ACG also recommends consideration of TIPS placement in patients with PVT and sequelae of portal hypertension, including variceal bleeding, refractory ascites, and hepatic hydrothorax.
- In the setting of chronic PVT secondary to cirrhosis, the mainstay of endovascular management is the creation of a transjugular intrahepatic portosystemic shunt with portal vein recanalization (PVR-TIPS).
- The ACG recommends the use of nonselective beta-blockers as first-line medical therapy, followed by endoscopic variceal ligation (strong recommendation, low quality of evidence).
View source ↗